Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort
Correction(s) for this article
-
Erratum
- Volume 142Issue 7International Journal of Cancer
- pages: E3-E3
- First Published online: February 8, 2018
Corresponding Author
Jo S Stenehjem
Department of Research, Cancer Registry of Norway, Oslo, Norway
Correspondence to: Jo S Stenehjem, PhD, Cancer Registry of Norway, P.O. box 5313 Majorstuen, N-0304 Oslo, Norway, Tel.: +4722451300, Fax: +4722451370, E-mail: [email protected]Search for more papers by this authorMarit B Veierød
Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
Search for more papers by this authorLill Tove Nilsen
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorReza Ghiasvand
Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
Search for more papers by this authorBjørn Johnsen
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorTom K Grimsrud
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorRonnie Babigumira
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorJudith R Rees
New Hampshire State Cancer Registry, Lebanon, NH
Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH
Search for more papers by this authorTrude E Robsahm
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorCorresponding Author
Jo S Stenehjem
Department of Research, Cancer Registry of Norway, Oslo, Norway
Correspondence to: Jo S Stenehjem, PhD, Cancer Registry of Norway, P.O. box 5313 Majorstuen, N-0304 Oslo, Norway, Tel.: +4722451300, Fax: +4722451370, E-mail: [email protected]Search for more papers by this authorMarit B Veierød
Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
Search for more papers by this authorLill Tove Nilsen
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorReza Ghiasvand
Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
Search for more papers by this authorBjørn Johnsen
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorTom K Grimsrud
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorRonnie Babigumira
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorJudith R Rees
New Hampshire State Cancer Registry, Lebanon, NH
Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH
Search for more papers by this authorTrude E Robsahm
Department of Research, Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorAbstract
The aim of the present study was to prospectively examine risk of cutaneous melanoma (CM) according to measured anthropometric factors, adjusted for exposure to ultraviolet radiation (UVR), in a large population-based cohort in Norway. The Janus Cohort, including 292,851 Norwegians recruited 1972–2003, was linked to the Cancer Registry of Norway and followed for CM through 2014. Cox regression was used to estimate hazard ratios (HRs) of CM with 95% confidence intervals (CIs). Restricted cubic splines were incorporated into the Cox models to assess possible non-linear relationships. All analyses were adjusted for attained age, indicators of UVR exposure, education, and smoking status. During a mean follow-up of 27 years, 3,000 incident CM cases were identified. In men, CM risk was positively associated with body mass index, body surface area (BSA), height and weight (all ptrends < 0.001), and the exposure-response curves indicated an exponential increase in risk for all anthropometric factors. Weight loss of more than 2 kg in men was associated with a 53% lower risk (HR 0.47, 95% CI: 0.39, 0.57). In women, CM risk increased with increasing BSA (ptrend = 0.002) and height (ptrend < 0.001). The shape of the height-CM risk curve indicated an exponential increase. Our study suggests that large body size, in general, is a CM risk factor in men, and is the first to report that weight loss may reduce the risk of CM among men.
Abstract
What's new?
Anthropometric factors, such as height and weight, affect melanoma risk, according to new results. These authors looked at data from a large Norwegian cohort, including 3000 cases of cutaneous melanoma. They found that body mass index, body surface area, weight, and height all influence CM risk in males, with an exponential increase for all factors. In women, only height and body surface area correlated with cancer risk – possibly because women with higher weight and BMI sunbathe less. They further showed that men who reduced their weight by 2 kg or more also lowered their melanoma risk.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
ijc31086-sup-0001-suppinfo1.docx38.5 KB |
Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Whiteman DC, Green AC, Olsen CM. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. J Invest Dermatol 2016; 136: 1161–71.
- 2 Karimkhani C, Green AC, Nijsten T, et al. The Global Burden of Melanoma: Results from Global Burden of Disease Study 2015. Br J Dermatol 2017; 177: 134–40.
- 3 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374–403.
- 4 Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105: S77–81.
- 5 Berwick M, Buller DB, Cust A, et al. Melanoma Epidemiology and Prevention. Cancer Treat Res 2016; 167: 17–49.
- 6 Lahmann PH, Hughes MC, Williams GM, et al. A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma. Cancer Epidemiol 2016; 40: 119–25.
- 7 Thune I, Olsen A, Albrektsen G, et al. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway. Int J Cancer 1993; 55: 555–61.
- 8
Veierod MB,
Thelle DS,
Laake P. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 1997; 71: 600–4.
10.1002/(SICI)1097-0215(19970516)71:4<600::AID-IJC15>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 9 Samanic C, Chow WH, Gridley G, et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901–9., Jr.,
- 10 Dennis LK, Lowe JB, Lynch CF, et al. Cutaneous melanoma and obesity in the Agricultural Health Study. Ann Epidemiol 2008; 18: 214–21.
- 11 Pothiawala S, Qureshi AA, Li Y, et al. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control 2012; 23: 717–26.
- 12 Gallus S, Naldi L, Martin L, et al. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res 2006; 16: 83–7.
- 13 Shors AR, Solomon C, McTiernan A, et al. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control 2001; 12: 599–606.
- 14 Le Marchand L, Saltzman BS, Hankin JH, et al. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol 2006; 164: 232–45.
- 15 Olsen CM, Green AC, Zens MS, et al. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer 2008; 122: 1100–8.
- 16 Sergentanis TN, Antoniadis AG, Gogas HJ, et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer 2013; 49: 642–57.
- 17 Tang JY, Henderson MT, Hernandez-Boussard T, et al. Lower skin cancer risk in women with higher body mass index: the women's health initiative observational study. Cancer Epidemiol Biomarkers Prev 2013; 22: 2412–5.
- 18 Hjerkind KV, Gislefoss RE, Tretli S, et al. Cohort Profile Update: The Janus Serum Bank Cohort in Norway. Int J Epidemiol 2017; 46: 1101–2f.
- 19 Stenehjem JS, Grimsrud TK, Rees JR, et al. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival. BMJ Open 2017; 7.
- 20 Lentner C. Geigy Scientific Tables. Vol 1: Units of Measurement, Body Fluids, Composition of the Body. Nutrition Basle, Switzerland: Ciba-Geigy Limited, 1981.
- 21 World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England) 2004; 363: 157–63.
- 22 Alfonso JH, Martinsen JI, Pukkala E, et al. Occupation and relative risk of cutaneous squamous cell carcinoma (cSCC): A 45-year follow-up study in 4 Nordic countries. J Am Acad Dermatol 2016; 75: 548–55.
- 23 Medhaug I, Olseth JA, Reuder J. UV radiation and skin cancer in Norway. J Photochem Photobiol B Biol 2009; 96: 232–41.
- 24 Lund E, Dumeaux V, Braaten T, et al. Cohort profile: The Norwegian Women and Cancer Study–NOWAC–Kvinner og kreft. Int J Epidemiol 2008; 37: 36–41.
- 25Norwegian-Cancer-Society, Solvaner i den norske befolkningen (Sunhabits in the Norwegian population). Report in Norwegian, 2012.
- 26 Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218–31.
- 27 Robsahm TE, Bergva G, Hestvik UE, et al. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954–2008. Melanoma Res 2013; 23: 70–8.
- 28 Rogers W. Regression standard errors in clustered samples. Stata Tech Bull 1994; 3.
- 29 Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (2005) 2008; 32: S56–9.
- 30 Lambert P. partpred: Stata module to generate partial predictions. University of Leicester, UK. Statistical Software Components S457176, 2010. Available at: https://ideas.repec.org/c/boc/bocode/s457176.html. (revised 2013).
- 31 Lambert P. rcsgen: Stata module to generate restricted cubic splines and their derivates. University of Leicester, UK. Statistical Software Components S456986, 2008. Available at: https://ideas.repec.org/c/boc/bocode/s456986.html. (revised 2015).
- 32 Newson RB. Attributable and unattributable risks and fractions and other scenario comparisons. Stata J 2013; 13: 672–98.
- 33 Præstegaard C, Kjær SK, Christensen J, et al. Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study. J Invest Dermatol 2015; 135: 901.
- 34 Veierod MB, Weiderpass E, Thorn M, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003; 95: 1530–8.
- 35 Botteri E, Støer NC, Sakshaug S, et al. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Int J Cancer 2017; 141: 1763–70.
- 36 Hopkins BD, Goncalves MD, Cantley LC. Obesity and Cancer Mechanisms: Cancer Metabolism. J Clin Oncol 2016; 34: 4277–83.
- 37 Engelman JA, Cantley LC. Chemoprevention meets glucose control. Cancer Prev Res 2010; 3: 1049–52.
- 38 Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–91.
- 39 Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21–34.
- 40 Gogas H, Trakatelli M, Dessypris N, et al. Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 2008; 19: 384–9.
- 41 Morpurgo G, Fioretti B, Catacuzzeno L. The increased incidence of malignant melanoma in obese individuals is due to impaired melanogenesis and melanocyte DNA repair. Med Hypotheses 2012; 78: 533–5.
- 42 Kabat GC, Kim MY, Hollenbeck AR, et al. Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 2014; 25: 1697–706.
- 43 Wiren S, Haggstrom C, Ulmer H, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 2014; 25: 151–9.
- 44 Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 1988; 80: 772–5.
- 45 Wadsworth ME, Hardy R, Paul A, et al. Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort. Int J Epidemiol 2002; 31: 383–90.
- 46 Ross MH, Bras G. Lasting influence of early caloric restriction on prevalence of neoplasms in the rat. J Natl Cancer Inst 1971; 47: 1095–114.
- 47 Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534–42.
- 48 Kabat GC, Anderson ML, Heo M, et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2013; 22: 1353–63.
- 49 Lango Allen H, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832–8.
- 50 Flegal KM. Body-mass index and all-cause mortality. Lancet 389: 2284–5.
- 51 Bjartveit K, Foss OP, Gjervig T, et al. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979; 634: 1–70.